CN Patent

CN107253975A — 硼酸酯化合物及其医药组合物

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2017-10-17 · 9y expired

What this patent protects

本发明提供适用作蛋白酶体抑制剂的新颖化合物。本发明还提供包含本发明的化合物的医药组合物，及使用所述组合物治疗各种疾病的方法。

USPTO Abstract

本发明提供适用作蛋白酶体抑制剂的新颖化合物。本发明还提供包含本发明的化合物的医药组合物，及使用所述组合物治疗各种疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN107253975A
Jurisdiction
CN
Classification
—
Expires
2017-10-17
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.